Ino, H., Nakazawa, E., & Akabayashi, A. (2021). Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps. Cambridge quarterly of healthcare ethics, 30(1), 51-58. doi:10.1017/S0963180120000481
Цитирование в стиле Чикаго (17-е изд.)Ino, Hiroyasu, Eisuke Nakazawa, и Akira Akabayashi. "Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps." Cambridge Quarterly of Healthcare Ethics 30, no. 1 (2021): 51-58, https://doi.org/10.1017/S0963180120000481.
Цитирование MLA (8-е изд.)Ino, Hiroyasu, et al. "Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps." Cambridge Quarterly of Healthcare Ethics, vol. 30, no. 1, 2021, pp. 51-58, https://doi.org/10.1017/S0963180120000481.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.